Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Fatty Acid Desaturase Involvement in Non-Alcoholic Fatty Liver Disease Rat Models: Oxidative Stress Versus Metalloproteinases.

Palladini G, Di Pasqua LG, Berardo C, Siciliano V, Richelmi P, Mannucci B, Croce AC, Rizzo V, Perlini S, Vairetti M, Ferrigno A.

Nutrients. 2019 Apr 8;11(4). pii: E799. doi: 10.3390/nu11040799.

2.

Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress.

Palladini G, Di Pasqua LG, Berardo C, Siciliano V, Richelmi P, Perlini S, Ferrigno A, Vairetti M.

Can J Gastroenterol Hepatol. 2019 Feb 3;2019:5413461. doi: 10.1155/2019/5413461. eCollection 2019.

3.

Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells.

Imperlini E, Gnecchi M, Rognoni P, Sabidò E, Ciuffreda MC, Palladini G, Espadas G, Mancuso FM, Bozzola M, Malpasso G, Valentini V, Palladini G, Orrù S, Ferraro G, Milani P, Perlini S, Salvatore F, Merlini G, Lavatelli F.

Sci Rep. 2017 Nov 15;7(1):15661. doi: 10.1038/s41598-017-15424-3.

4.

Effects of a Bioavailable Arabinoxylan-enriched White Bread Flour on Postprandial Glucose Response in Normoglycemic Subjects.

Giulia Falchi A, Grecchi I, Muggia C, Palladini G, Perlini S.

J Diet Suppl. 2016 Nov;13(6):626-33. doi: 10.3109/19390211.2016.1156798. Epub 2016 Apr 6.

PMID:
27049812
5.

Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review.

Palladini G, Ferrigno A, Richelmi P, Perlini S, Vairetti M.

World J Gastroenterol. 2015 Nov 14;21(42):12114-24. doi: 10.3748/wjg.v21.i42.12114. Review.

6.

Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis.

Lavatelli F, Imperlini E, Orrù S, Rognoni P, Sarnataro D, Palladini G, Malpasso G, Soriano ME, Di Fonzo A, Valentini V, Gnecchi M, Perlini S, Salvatore F, Merlini G.

FASEB J. 2015 Nov;29(11):4614-28. doi: 10.1096/fj.15-272179. Epub 2015 Jul 28.

PMID:
26220173
7.

Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis.

Ferrigno A, Palladini G, Bianchi A, Rizzo V, Di Pasqua LG, Perlini S, Richelmi P, Vairetti M.

Biomed Res Int. 2014;2014:327537. doi: 10.1155/2014/327537. Epub 2014 Jun 12.

8.

Lung matrix metalloproteinase activation following partial hepatic ischemia/reperfusion injury in rats.

Palladini G, Ferrigno A, Rizzo V, Tarantola E, Bertone V, Freitas I, Perlini S, Richelmi P, Vairetti M.

ScientificWorldJournal. 2014 Jan 23;2014:867548. doi: 10.1155/2014/867548. eCollection 2014.

9.

A multimarker study of degenerative aortic valve disease: stenoinsufficiency shows more indices of bad prognosis.

Vianello A, Perlini S, Cappelli S, Palladini G, Epistolato MC, Della Latta D, Cerillo A, Berti S, Chiappino D, Tanganelli P, Glauber M, Mazzone A.

Cardiology. 2013;124(2):126-37. doi: 10.1159/000346396. Epub 2013 Feb 21.

PMID:
23428667
10.

Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers.

Palladini G, Ferrigno A, Rizzo V, Boncompagni E, Richelmi P, Freitas I, Perlini S, Vairetti M.

Toxicol Pathol. 2012 Jul;40(5):722-30. doi: 10.1177/0192623312441403. Epub 2012 May 1.

PMID:
22549974
11.

Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload.

Falcão-Pires I, Palladini G, Gonçalves N, van der Velden J, Moreira-Gonçalves D, Miranda-Silva D, Salinaro F, Paulus WJ, Niessen HW, Perlini S, Leite-Moreira AF.

Basic Res Cardiol. 2011 Sep;106(5):801-14. doi: 10.1007/s00395-011-0184-x. Epub 2011 May 1.

PMID:
21533831
12.

Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy.

Tozzi R, Palladini G, Fallarini S, Nano R, Gatti C, Presotto C, Schiavone A, Micheletti R, Ferrari P, Fogari R, Perlini S.

Am J Hypertens. 2007 Jun;20(6):663-9.

PMID:
17531925
13.

Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure.

Perlini S, Arosio B, Parmeggiani L, Santambrogio D, Palladini G, Tozzi R, Gatti C, Annoni G, Meyer TE, Ferrari AU.

J Hypertens. 2007 Feb;25(2):449-54.

PMID:
17211253
14.

Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure.

Perlini S, Ferrero I, Palladini G, Tozzi R, Gatti C, Vezzoli M, Cesana F, Janetti MB, Clari F, Busca G, Mancia G, Ferrari AU.

Hypertension. 2006 Jul;48(1):93-7. Epub 2006 Jun 5.

PMID:
16754795
15.

Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy.

Perlini S, Palladini G, Ferrero I, Tozzi R, Fallarini S, Facoetti A, Nano R, Clari F, Busca G, Fogari R, Ferrari AU.

Hypertension. 2005 Nov;46(5):1213-8. Epub 2005 Oct 10.

PMID:
16216989
16.

Cardiac mast cells in the transition to heart failure: innocent bystanders or key actors?

Palladini G, Tozzi R, Perlini S.

J Hypertens. 2003 Oct;21(10):1823-5. Review. No abstract available.

PMID:
14508186
17.

Adenosine A1 and A2A receptor cross-talk during ageing in the rat myocardium.

Arosio B, Perlini S, Calabresi C, Tozzi R, Palladini G, Ferrari AU, Vergani C, Annoni G.

Exp Gerontol. 2003 Aug;38(8):855-61.

PMID:
12915207

Supplemental Content

Loading ...
Support Center